N-(Benzoylcarbamoyl)-beta-D-glucopyranosylamine

N-(Benzoylcarbamoyl)-beta-D-glucopyranosylamine is an experimental small molecule inhibitor of glycogen phosphorylase (muscle form). It belongs to the class of organic compounds known as hexoses and is structurally a glucopyranose derivative with a benzoylurea moiety. The compound has been studied as a potential antidiabetic agent due to its ability to inhibit glycogen breakdown by targeting muscle glycogen phosphorylase. No approved indications or advanced clinical development have been reported for this molecule[1][2][7].

Other names

N-benzoyl-N'-beta-D-glucopyranosyl ureaN-[(phenylcarbonyl)carbamoyl]-beta-D-glucopyranosylamineN-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl]benzamide